Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC
Clinical trial NCT02824094 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02824094
- Sponsor
- Pfizer
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.